Your browser doesn't support javascript.
loading
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia.
Tirtakusuma, Ricky; Szoltysek, Katarzyna; Milne, Paul; Grinev, Vasily V; Ptasinska, Anetta; Chin, Paulynn S; Meyer, Claus; Nakjang, Sirintra; Hehir-Kwa, Jayne Y; Williamson, Daniel; Cauchy, Pierre; Keane, Peter; Assi, Salam A; Ashtiani, Minoo; Kellaway, Sophie G; Imperato, Maria R; Vogiatzi, Fotini; Schweighart, Elizabeth K; Lin, Shan; Wunderlich, Mark; Stutterheim, Janine; Komkov, Alexander; Zerkalenkova, Elena; Evans, Paul; McNeill, Hesta; Elder, Alex; Martinez-Soria, Natalia; Fordham, Sarah E; Shi, Yuzhe; Russell, Lisa J; Pal, Deepali; Smith, Alex; Kingsbury, Zoya; Becq, Jennifer; Eckert, Cornelia; Haas, Oskar A; Carey, Peter; Bailey, Simon; Skinner, Roderick; Miakova, Natalia; Collin, Matthew; Bigley, Venetia; Haniffa, Muzlifah; Marschalek, Rolf; Harrison, Christine J; Cargo, Catherine A; Schewe, Denis; Olshanskaya, Yulia; Thirman, Michael J; Cockerill, Peter N.
  • Tirtakusuma R; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Szoltysek K; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Milne P; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Grinev VV; Maria Sklodowska-Curie Institute, Oncology Center, Gliwice Branch, Gliwice, Poland.
  • Ptasinska A; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Chin PS; Department of Genetics, the Faculty of Biology, Belarusian State University, Minsk, Republic of Belarus.
  • Meyer C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Nakjang S; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Hehir-Kwa JY; Institute of Pharmaceutical Biology/DCAL, Goethe-University, Frankfurt/Main, Germany.
  • Williamson D; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Cauchy P; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Keane P; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Assi SA; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Ashtiani M; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Kellaway SG; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Imperato MR; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Vogiatzi F; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Schweighart EK; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Lin S; ALL-BFM Study Group, Pediatric Hematology/Oncology, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Wunderlich M; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Stutterheim J; Experimental Hematology and Cancer Biology, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Komkov A; Experimental Hematology and Cancer Biology, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Zerkalenkova E; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Evans P; Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia.
  • McNeill H; Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia.
  • Elder A; Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, United Kingdom.
  • Martinez-Soria N; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Fordham SE; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Shi Y; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Russell LJ; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Pal D; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Smith A; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Kingsbury Z; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Becq J; Epidemiology and Cancer Statistics Group, University of York, York, United Kingdom.
  • Eckert C; Illumina Cambridge Ltd., Great Abington, United Kingdom.
  • Haas OA; Illumina Cambridge Ltd., Great Abington, United Kingdom.
  • Carey P; Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Bailey S; St Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
  • Skinner R; Department of Paediatric Haematology and Oncology, The Great North Children's Hospital, Newcastle upon Tyne, United Kingdom.
  • Miakova N; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Collin M; Department of Paediatric Haematology and Oncology, The Great North Children's Hospital, Newcastle upon Tyne, United Kingdom.
  • Bigley V; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Haniffa M; Department of Paediatric Haematology and Oncology, The Great North Children's Hospital, Newcastle upon Tyne, United Kingdom.
  • Marschalek R; Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia.
  • Harrison CJ; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Cargo CA; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Schewe D; Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Olshanskaya Y; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
  • Thirman MJ; Department of Dermatology and Newcastle National Institute of Health Research (NIHR), Newcastle Biomedical Research Centre, Newcastle Hospitals National Health Service (NHS) Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Cockerill PN; Institute of Pharmaceutical Biology/DCAL, Goethe-University, Frankfurt/Main, Germany.
Blood ; 140(17): 1875-1890, 2022 10 27.
Article en En | MEDLINE | ID: mdl-35839448
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína de la Leucemia Mieloide-Linfoide / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína de la Leucemia Mieloide-Linfoide / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article